Certified by Founder Lodge
Nimbus Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $125,000,000
0 Participating Investments
-
Founded date
2009
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 13 ,2022 | Unknown | $125,000,000 |
Bain Capital
Atlas Venture
SV Health Investors
Pfizer
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Whirl AI | $8,900,000 | (Apr 2, 2026)
Cara | $8,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
